CLINICAL_TRIALS
trial_result
· 2010-12-17
Clinical Trial Update: Duloxetine for the Treatment of Generalized Anxiety Disorder [Phase 3]
Summary
Phase 3 trial results for duloxetine in generalized anxiety disorder have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Generalized Anxiety Disorder | Phase 3 | Status: COMPLETED | Results posted: 2010-12-17